Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis ZYDUSLIFE

Max Ratio

2.95

Dividend Yield

1.82 %

5Y Dividend Growth

71.00 %

Consecutive Years

5Y Average Payout Ratio

19.95 %

Dividend History ZYDUSLIFE

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 1.82 %
Consecutive Years 0
Forward Annual Dividend 17.00 INR
Consistent Years 2
Dividend CAGR 3Y 19.68 %
Continuous Dividends
Dividend CAGR 5Y 11.38 %
Payout Ratio TTM 22.50 %
Dividend CAGR 10Y 12.79 %
Ex Dividend Date 07/25/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth ZYDUSLIFE

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin ZYDUSLIFE

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income ZYDUSLIFE

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM ZYDUSLIFE

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio ZYDUSLIFE

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Zydus Lifesciences Limited ZYDUSLIFE

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself ZYDUSLIFE

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 19.16
Forward PE 21.60
Enterprise Value Revenue 4.02
Price Sales TTM 3.85
Enterprise Value EBITDA 12.51
Price Book MRQ 3.72

Zydus Lifesciences Limited Dividends: 1.18 % Yield, History, Payment Schedule

ZYDUSLIFE
Current price
935.75 INR -2.24 INR (-0.24%)
Last closed 934.95 INR
ISIN INE010B01027
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange National Stock Exchange of India
Capitalization 944 424 372 699 INR
Yield for 12 month -4.32 %
1Y
3Y
5Y
10Y
15Y
ZYDUSLIFE
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+232 805 243 487 INR

Last Year

+195 802 216 591 INR

Current Quarter

+61 334 813 433 INR

Last Quarter

+65 847 377 758 INR

Current Year

+167 311 458 547 INR

Last Year

+131 757 861 246 INR

Current Quarter

+31 017 994 398 INR

Last Quarter

+47 922 330 560 INR
EBITDA 69 498 494 521 INR
Operating Margin TTM 21.23 %
Price to Earnings 19.16
Return On Assets TTM 9.54 %
PEG Ratio
Return On Equity TTM 19.25 %
Wall Street Target Price 91 359.68 INR
Revenue TTM 245 350 270 082 INR
Book Value 251.91 INR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 16.90 %
Dividend Yield 1.82 %
Gross Profit TTM 175 624 394 101 INR
Earnings per share 48.98 INR
Diluted Eps TTM 48.98 INR
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY 38.10 %
Profit Margin 20.09 %

Technical Indicators ZYDUSLIFE

For 52 Weeks

787.31 INR 1 060.83 INR
50 Day MA 971.25 INR
Shares Short Prior Month
200 Day MA 949.51 INR
Short Ratio
Shares Short
Short Percent